Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial.
Additional genomic findings
Diagnostic sequencing
Genomic sequencing
Randomized controlled trial
Test-related distress
Journal
Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
21
01
2021
revised:
31
03
2021
accepted:
22
04
2021
pubmed:
11
5
2021
medline:
1
2
2022
entrez:
10
5
2021
Statut:
ppublish
Résumé
Many people prefer to learn secondary or "additional" findings from genomic sequencing, including findings with limited medical actionability. Research has investigated preferences for and effects of learning such findings, but not psychosocial and behavioral effects of receiving education about them and the option to request them, which could be burdensome or beneficial (e.g., causing choice overload or satisfying strong preferences, respectively). 335 adults with suspected genetic disorders who had diagnostic exome sequencing in a research study and were randomized to receive either diagnostic findings only (DF; n = 171) or diagnostic findings plus education about additional genomic findings and the option to request them (DF + EAF; n = 164). Assessments occurred after enrollment (Time 1), after return of diagnostic results and-for DF + EAF-the education under investigation (Time 2), and three and six months later (Times 3, 4). Time 2 test-related distress, test-related uncertainty, and generalized anxiety were lower in the DF + EAF group (ps = 0.025-0.043). There were no other differences. Findings show limited benefits and no harms of providing education about and the option to learn additional findings with limited medical actionability. Findings can inform recommendations for returning additional findings from genomic sequencing (e.g., to research participants or after commercial testing).
Identifiants
pubmed: 33966955
pii: S0738-3991(21)00291-3
doi: 10.1016/j.pec.2021.04.026
pmc: PMC8553797
mid: NIHMS1700076
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT01969370']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Pagination
2989-2998Subventions
Organisme : NHGRI NIH HHS
ID : U01 HG006487
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declarations of interest None.